Practical approach to the use of daylight photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: a European consensus
- 28 January 2015
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 29 (9), 1718-1723
- https://doi.org/10.1111/jdv.12974
Abstract
Introduction Daylight‐mediated photodynamic therapy has been shown to be an effective therapy for actinic keratoses (AKs) and a simple and tolerable treatment procedure in three randomized Scandinavian studies and two recent Phase III randomized controlled studies in Australia and Europe. Objectives To establish consensus recommendations for the use of daylight photodynamic therapy (DL‐PDT) using topical methyl aminolaevulinate (MAL) in European patients with AKs. Methods The DL‐PDT consensus recommendations were developed on behalf of the European Society for Photodynamic Therapy in Dermatology and comprised of 10 dermatologists from different European countries with experience in how to treat AK patients with PDT. Consensus was developed based on literature review and experience of the experts in the treatment of AK using DL‐PDT. Results The recommendations arising from this panel of experts provide general guidance on the use of DL‐PDT as a dermatological procedure with specific guidance regarding patient selection, therapeutic indications, when to treat, pre‐treatment skin preparation, MAL application and daylight exposure for patients with AK in different countries of Europe. Conclusions This consensus recommendation provides a framework for physicians to perform DL‐PDT with MAL cream while ensuring efficiency and safety in the treatment of patients with AK in different European countries.Keywords
Funding Information
- Galderma International, Paris, France
This publication has 17 references indexed in Scilit:
- Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled studyBritish Journal of Dermatology, 2014
- Photodynamische Therapie zur Hautverjüngung: Behandlungsoptionen — Ergebnisse einer Konsensus‐Konferenz des Arbeitskreises Ästhetische Photodynamische TherapieJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2013
- Daylight‐mediated photodynamic therapy of basal cell carcinomas – an explorative studyJournal of the European Academy of Dermatology and Venereology, 2013
- Daylight Photodynamic Therapy in Private Practice in Switzerland: Gain Without PainActa Dermato Venereologica, 2012
- Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locationsBritish Journal of Dermatology, 2012
- Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre studyBritish Journal of Dermatology, 2012
- Daylight photodynamic therapy for actinic keratosis: an international consensusJournal of the European Academy of Dermatology and Venereology, 2011
- A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalpBritish Journal of Dermatology, 2011
- Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolaevulinate and home-based daylight exposure: a double-blinded randomized clinical trialBritish Journal of Dermatology, 2009
- Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded studyBritish Journal of Dermatology, 2008